Technique reveals proteins moving as they work

Researchers at Weill Cornell Medicine have shown the ability to record the high-speed motions of proteins while correlating their motion to function, which should allow scientists to study proteins in greater detail than ever before.

Dr. Geraldine McGinty appointed senior associate dean for clinical affairs

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.

Around Cornell

Red blood cell alterations contribute to lupus

The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells (RBCs), according to a study led by researchers at Weill Cornell Medicine. The discovery could lead to new methods for classifying and treating patients with this disease.

Cancer vaccine improves outcomes in Lynch syndrome model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

BioEntrepreneurship program to fuel NYS life science startups

The Samuel Curtis Johnson Graduate School of Management is announcing a new BioEntrepreneurship Initiative to connect MBA students and life science researchers to life science companies in NYS while catalyzing the formation of new life science startups.

Researchers find new insight into how the brain decides to act

Researchers at Weill Cornell Medicine have identified neurons that drive animal brains to initiate actions without prompting from food or prey – a big step toward solving a big unanswered questions in neuroscience.

Treatment with endothelial cells reverses emphysema in model

The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Research suggests how tumors become aggressive prostate cancer

The genetic changes that underlie an especially lethal type of prostate cancer, called neuroendocrine prostate cancer, have been revealed in a new study at Weill Cornell Medicine. Learning more about what causes this type of cancer could lead to new approaches for treating it.

Black patients with liver disease may face obstacles to transplants

Black patients who have chronic liver failure, also known as end-stage liver disease, are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study.